BB Biotech AG

Swiss Stock Exchange BION.SW

BB Biotech AG Revenue Per Share for the year ending December 31, 2023

BB Biotech AG Revenue Per Share is NA for the year ending December 31, 2023. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.

BB Biotech AG Revenue Per Share for the year ending December 31, 2020 was USD 14.26, a 11.68% change year over year.
BB Biotech AG Revenue Per Share for the year ending December 31, 2019 was USD 12.77.

Key data

Date	Revenue Per Share	Dividend Per Share	Free Cash Flow Per Share	Return on Assets (ROA)

Swiss Stock Exchange: BION.SW

BB Biotech AG

CEO	Dr. Daniel Koller Ph.D.
IPO Date	Jan. 4, 2000
Location	Switzerland
Headquarters	Seestrasse 16
Employees	10
Sector	Health Care
Industries Biotechnology Hedge Funds Private Equity

Description

BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.

Key trends

Past 5 years